Polypodium leucotomos for Skin Rejuvenation - Quick Reference Sheet
evipedia.ai ← Back

Polypodium leucotomos for Skin Rejuvenation

Created on 06/23/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 – Audit

An oral fern extract used as an inside-out aid for sun-aged skin. Its most dependable effect is a modest, short-lived rise in how much sun the skin tolerates before reddening. Pigment benefits are smaller and work best added to other treatments. Visible wrinkle reversal remains unproven. Well tolerated; not a sunscreen substitute. (Full Review)

Protocol

Dose
240 mg
Standardized extract by mouth (capsule); total daily doses across studies range 120–1,080 mg
Timing
~30 min before sun
Taken ~30 minutes before anticipated sun exposure; for chronic adjuvant use, a consistent daily time with food
Heavy Exposure
Second 240 mg
On days of heavy exposure, a second 240 mg capsule a few hours later; split dosing preferred for prolonged exposure
Time to effect
Photoprotection
Within hours
Raised UV tolerance appears within hours of a single dose and over a few days of consistent dosing
Melasma
8–12 weeks
Pigment-related improvements are gradual, typically assessed over 8–12 weeks of adjunctive use
Vitiligo
8–12 weeks
Repigmentation with phototherapy is gradual, reviewed clinically over 8–12 weeks of adjunctive use

Benefits

Contraindications
  • Pregnancy or breastfeeding
  • Known fern or plant allergies
  • Immunosuppressant therapy (e.g., post-transplant patients)
    •
Key Interactions
  • Photosensitizing prescription drugs (e.g., doxycycline, hydrochlorothiazide, amiodarone)
  • OTC photosensitizing agents (e.g., topical retinoids, ibuprofen)
  • Other oral photoprotective supplements (carotenoids, polyphenols, nicotinamide, omega-3)
  • Phototherapy or psoralen plus UVA for vitiligo
    •

Risk & Side Effects

  • High: [risks_high]
    •
  • Medium: Mild gastrointestinal upset
    •
  • Low: Pruritus and mild skin reactions; false sense of security
    •
  • Speculative: Theoretical hepatic and long-term effects; interaction-related harm in vulnerable users
    •

Monitoring

Marker Target Why
ALT ~10–26 U/L (functional) Screens for the speculative long-term liver effect of prolonged botanical use
AST ~10–26 U/L (functional) Complements ALT to detect any liver stress
25-hydroxyvitamin D 40–60 ng/mL Reduced sun exposure (encouraged alongside the extract) can lower vitamin D
hs-CRP < 1.0 mg/L Optional gauge of systemic oxidative/inflammatory load the extract targets

Cadence: Baseline for prolonged daily use; liver enzymes rechecked at ~6–12 months; outcomes reviewed at 8–12 weeks then periodically; vitamin D at baseline and seasonally

Qualitative Assessment

  • Improved tolerance to sun exposure (less rapid reddening or burning)
  • Reduced frequency or severity of sun-triggered rash (for those with polymorphic light eruption)
  • Gradual evening of facial pigmentation (for melasma)
  • Subjective skin comfort and absence of side effects (no stomach upset or itching)
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.